A detailed history of Atria Investments LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Atria Investments LLC holds 7,497 shares of ZLAB stock, worth $163,059. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,497
Previous 8,074 7.15%
Holding current value
$163,059
Previous $282,000 9.93%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$28.4 - $40.51 $16,386 - $23,374
-577 Reduced 7.15%
7,497 $254,000
Q2 2025

Aug 04, 2025

BUY
$24.32 - $43.03 $29,402 - $52,023
1,209 Added 17.61%
8,074 $282,000
Q1 2025

May 06, 2025

BUY
$24.29 - $38.35 $166,750 - $263,272
6,865 New
6,865 $248,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.13B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.